N S Turhal

Summary

Affiliation: Istanbul University
Country: Turkey

Publications

  1. ncbi request reprint Changes in lifestyle upon diagnosis of cancer or other chronic illnesses: A Turkish Oncology Group study
    Nazim Serdar Turhal
    Marmara University, Turkey
    J Health Psychol . 2016
  2. ncbi request reprint Personality traits in cancer patients
    Nazim Serdar Turhal
    Department of Internal Medicine, Division of Oncology, Marmara University Medical Faculty, Istanbul, Turkey E mail
    Asian Pac J Cancer Prev 14:4515-8. 2013
  3. pmc Results of paclitaxel (day 1 and 8) and carboplatin given on every three weeks in advanced (stage III-IV) non-small cell lung cancer
    Perran F Yumuk
    Division of Medical Oncology, Marmara University Hospital, Tophanelioglu C, 13 15 Altunizade, Uskudar, Istanbul 81190 Turkey
    BMC Cancer 5:10. 2005
  4. pmc Concurrent chemoradiotherapy with low dose weekly gemcitabine in stage III non-small cell lung cancer
    Ufuk Abacioglu
    Department of Radiation Oncology, Marmara University Medical School Hospital, Istanbul, Turkey
    BMC Cancer 5:71. 2005
  5. ncbi request reprint Cyclosporin A and imipenem associated seizure activity in allogeneic bone marrow transplantation patients
    N S Turhal
    Marmara University, Department of Internal Medicine, Division of Oncology, Istanbul, Turkey
    J Chemother 11:410-3. 1999
  6. ncbi request reprint ERCC1 is not expressed in hepatocellular cancer: A turkish oncology group, gastrointestinal oncology subgroup study
    N S Turhal
    Marmara University School of Medicine, Department of Medical Oncology, Istanbul, Turkey
    J BUON 15:794-6. 2010
  7. ncbi request reprint 99m-Tc-MDP-Scintimammography in the evaluation of breast masses or tumor angiogenesis
    Nazim S Turhal
    Department of Internal Medicine, Division of Oncology, Marmara University Hospital, Turkey
    Anticancer Res 24:1999-2006. 2004
  8. ncbi request reprint Efficacy of treatment to relieve mucositis-induced discomfort
    N S Turhal
    Department of Medicine, Marmara University Hospital, Istanbul, Turkey
    Support Care Cancer 8:55-8. 2000
  9. pmc Patient satisfaction in the outpatients' chemotherapy unit of Marmara University, Istanbul, Turkey: a staff survey
    Nazim S Turhal
    Marmara University, Department of Internal Medicine, Division of Oncology, Istanbul, Turkey
    BMC Cancer 2:30. 2002
  10. ncbi request reprint Prognostic significance of serum thymidine kinase activity (TK1) level in patients with metastatic non-small cell lung cancer (NSCLC)
    T Korkmaz
    Department of Medical Oncology, Marmara University School of Medicine, Istanbul, Turkey Medical Oncology Department, Marmara University Hospital, Istanbul, Turkey Medical Oncology Department of Marmara University, Istanbul, Turkey Marmara University Medical School Hospital, Istanbul, Turkey Marmara University Hospital, Istanbul, Turkey Medical Oncology Department, Istanbul Bilim University School of Medicine, Istanbul, Turkey Marmara University Hospital Medical Oncology Department, Istanbul, Turkey Medical Oncology Department, Bilim University, Istanbul, Turkey
    J Clin Oncol 29:e18010. 2011

Collaborators

Detail Information

Publications35

  1. ncbi request reprint Changes in lifestyle upon diagnosis of cancer or other chronic illnesses: A Turkish Oncology Group study
    Nazim Serdar Turhal
    Marmara University, Turkey
    J Health Psychol . 2016
    ..These findings may help to address cancer patients' needs and facilitate resource allocation accordingly...
  2. ncbi request reprint Personality traits in cancer patients
    Nazim Serdar Turhal
    Department of Internal Medicine, Division of Oncology, Marmara University Medical Faculty, Istanbul, Turkey E mail
    Asian Pac J Cancer Prev 14:4515-8. 2013
    ..This study was planned to investigate the personality traits of cancer patients in different treatment settings, and to correlate the demographics with the personality features...
  3. pmc Results of paclitaxel (day 1 and 8) and carboplatin given on every three weeks in advanced (stage III-IV) non-small cell lung cancer
    Perran F Yumuk
    Division of Medical Oncology, Marmara University Hospital, Tophanelioglu C, 13 15 Altunizade, Uskudar, Istanbul 81190 Turkey
    BMC Cancer 5:10. 2005
    ..We retrospectively reviewed the data of 51 consecutive patients receiving C and day 1 and 8 P chemotherapy (CT) regimen in advanced stage NSCLC to evaluate the efficacy and toxicity...
  4. pmc Concurrent chemoradiotherapy with low dose weekly gemcitabine in stage III non-small cell lung cancer
    Ufuk Abacioglu
    Department of Radiation Oncology, Marmara University Medical School Hospital, Istanbul, Turkey
    BMC Cancer 5:71. 2005
    ..Twenty-two consecutive patients were treated with concurrent CRT to demonstrate the tolerability and efficacy of low dose G given weekly as radiosensitizer in stage III NSCLC...
  5. ncbi request reprint Cyclosporin A and imipenem associated seizure activity in allogeneic bone marrow transplantation patients
    N S Turhal
    Marmara University, Department of Internal Medicine, Division of Oncology, Istanbul, Turkey
    J Chemother 11:410-3. 1999
    ....
  6. ncbi request reprint ERCC1 is not expressed in hepatocellular cancer: A turkish oncology group, gastrointestinal oncology subgroup study
    N S Turhal
    Marmara University School of Medicine, Department of Medical Oncology, Istanbul, Turkey
    J BUON 15:794-6. 2010
    ..Expression of ERCC1 in HCC is not known. In this study we aimed to find out whether a subset of HCC patients can be identified to benefit from cisplatin...
  7. ncbi request reprint 99m-Tc-MDP-Scintimammography in the evaluation of breast masses or tumor angiogenesis
    Nazim S Turhal
    Department of Internal Medicine, Division of Oncology, Marmara University Hospital, Turkey
    Anticancer Res 24:1999-2006. 2004
    ..We studied the correlation between MDP uptake and VEGF and compared the diagnostic accuracy of mammography versus MDP-scintimammography (MDP-S)...
  8. ncbi request reprint Efficacy of treatment to relieve mucositis-induced discomfort
    N S Turhal
    Department of Medicine, Marmara University Hospital, Istanbul, Turkey
    Support Care Cancer 8:55-8. 2000
    ..91 (range 0-2.7). These results suggests that this three-drug mouthwash provides effective symptomatic relief in patients with chemotherapy-induced mucositis...
  9. pmc Patient satisfaction in the outpatients' chemotherapy unit of Marmara University, Istanbul, Turkey: a staff survey
    Nazim S Turhal
    Marmara University, Department of Internal Medicine, Division of Oncology, Istanbul, Turkey
    BMC Cancer 2:30. 2002
    ..We conducted a survey to find out how patients feel about the care they receive in the outpatient chemotherapy unit of Marmara University Hospital...
  10. ncbi request reprint Prognostic significance of serum thymidine kinase activity (TK1) level in patients with metastatic non-small cell lung cancer (NSCLC)
    T Korkmaz
    Department of Medical Oncology, Marmara University School of Medicine, Istanbul, Turkey Medical Oncology Department, Marmara University Hospital, Istanbul, Turkey Medical Oncology Department of Marmara University, Istanbul, Turkey Marmara University Medical School Hospital, Istanbul, Turkey Marmara University Hospital, Istanbul, Turkey Medical Oncology Department, Istanbul Bilim University School of Medicine, Istanbul, Turkey Marmara University Hospital Medical Oncology Department, Istanbul, Turkey Medical Oncology Department, Bilim University, Istanbul, Turkey
    J Clin Oncol 29:e18010. 2011
    ..The prognostic significance of TK1 activity in hematological malignancies and early stage solid cancers are well studied but little is known about the prognostic significance of TK1 activity in metastatic NSCL cancer...
  11. ncbi request reprint Clinical features and outcome of adjuvant chemoradiotherapy in Turkish rectal carcinoma patients: Single institution experience
    F Dane
    Marmara University Medical Oncology, Istanbul, Turkey Marmara University Radiation Oncology, Istanbul, Turkey
    J Clin Oncol 26:15103. 2008
    ..Therefore, we aimed to analyze the treatment outcome, and the prognostic significance of various parameters in these patients...
  12. ncbi request reprint Clinical outcome of triple-negative (TN) breast cancer (BC)
    D Cabuk
    MUTFH, Istanbul, Turkey
    J Clin Oncol 26:11526. 2008
    ..Triple- negative tumors, most of which fall into the basal subgroup of breast cancers based on microarray profiling have been reported to have an aggressive clinical course...
  13. ncbi request reprint Benefit from adjuvant anthracyclines according to hormone receptor status
    G Atalay Basaran
    Marmara University Hospital, Istanbul, Turkey
    J Clin Oncol 26:11513. 2008
    ..11513 Background: Several trials have consistently reported that there is marked heterogeneity in the magnitude of chemotherapy benefit according to the level of hormone receptor expression...
  14. ncbi request reprint Assessing cancer-related myths in relatives of cancer patients and the general public: A Turkish Oncology Group study
    F Dane
    Marmara University Hospital, Istanbul, Turkey Medical Oncology Department, Marmara University Hospital, Istanbul, Turkey Gazi University Faculty of Medicine, Ankara, Turkey Marmara University, Istanbul, Turkey Marmara University School of Medicine, Istanbul, Turkey Department of Medical Oncology, Marmara University School of Medicine, Istanbul, Turkey
    J Clin Oncol 29:e16632. 2011
    ....
  15. ncbi request reprint Clinical/pathologic characteristics of diabetic patients with early breast cancer (BC) and their survival outcome
    S Seber
    Marmara University Hospital, Istanbul, Turkey Medical Oncology Department, Marmara University Hospital, Istanbul, Turkey Department of Medical Oncology, Marmara University School of Medicine, Istanbul, Turkey Marmara University Hospital Medical Oncology Department, Istanbul, Turkey Marmara University Medical School Hospital, Istanbul, Turkey
    J Clin Oncol 29:e11019. 2011
    ..e11019 Background: Diabetes mellitus is thought to be associated with adverse outcomes in BC and it might adversely affect decisions regarding treatment...
  16. ncbi request reprint Pulmonary toxicity in patients receiving docetaxel chemotherapy
    U Kefeli
    Marmara University School of Medicine, Istanbul, Turkey Marmara University School of Medicine, Istanbul, Turkey Kadikoy Sonomed Medical Imaging Center, Istanbul, Turkey
    J Clin Oncol 27:e13532. 2009
    ..This side effect had been reported mostly in non-small cell lung cancer patients receiving docetaxel. We aimed to investigate the pulmonary toxicity in patients receiving docetaxel chemotherapy other than lung cancer...
  17. doi request reprint Prolonged interval in prophylactic heparin flushing for maintenance of subcutaneous implanted port care in patients with cancer
    U Kefeli
    Department of Internal Medicine, Marmara University Medical School, Istanbul, Turkey
    Eur J Cancer Care (Engl) 18:191-4. 2009
    ..Prophylactic flushing of central venous ports with 1000 U of heparin in every 6 weeks might be a safe, easy, cheaper, comfortable and effective alternative to standard dose and schedule for preventing thrombosis and infections...
  18. ncbi request reprint Impact of dose reductions of platinum compounds on survival in stage IIIB/IV non-small cell lung cancer (NSCLC)
    P F Yumuk
    Marmara University Medical School Hospital, Istanbul, Turkey
    J Clin Oncol 27:e19055. 2009
    ..We aimed to determine the effect of dose reductions of platinums on outcome of stage IIIB/IV NSCLC...
  19. ncbi request reprint Correlation of high FDG uptake in PET/CT with poor prognosis in metastatic gastric adenocarcinoma
    M Canhoroz
    Medical Oncology Department, Uludag University Hospital, Bursa, Turkey Department of Medical Oncology, Marmara University School of Medicine, Istanbul, Turkey Medical Oncology Department, Marmara University Hospital, Istanbul, Turkey Department of Medical Oncology, Dr Lutfi Kirdar Kartal Education and Research Hospital, Istanbul, Turkey Medical Oncology Department, Istanbul Bilim University School of Medicine, Istanbul, Turkey Hematology Department, Marmara University Hospital, Istanbul, Turkey Nuclear Medicine Department, Marmara University Hospital, Istanbul, Turkey Marmara University Hospital, Istanbul, Turkey Medical Oncology Department, Dr Lutfi Kirdar Kartal Training and Research Hospital, Istanbul, Turkey Medical Oncology Department, Bilim University, Istanbul, Turkey
    J Clin Oncol 29:e14668. 2011
    ..18F-FDG PET may have a role in predicting patient prognosis on the basis of the metabolic activity of primary tumors (PT). We retrospectively evaluated prognostic value of FDG-PET/CT in metastatic gastric cancer...
  20. ncbi request reprint Impact of body mass index on cancer development
    P Fulden Yumuk
    Department of Internal Medicine, Division of Medical Oncology, Marmara University Medical School, Istanbul, Turkey
    J BUON 13:55-9. 2008
    ..To determine the impact of body mass index (BMI) on cancer in a hospital-based Turkish population...
  21. ncbi request reprint Cancer-related knowledge in relatives of cancer patients and general public in Istanbul, Turkey
    N S Turhal
    Marmara University School of Medicine, Istanbul, Turkey
    J Clin Oncol 26:20650. 2008
    ..The goal of our research is to measure knowledge of cancer in community. In addition, difference between knowledge of participants who have relatives with cancer and who do not and finding out where they get information that they have...
  22. doi request reprint Comparison of second-line treatment outcomes between sensitive and refractory small cell lung cancer patients: a retrospective analysis
    T Korkmaz
    Department of Medical Oncology, Dr Lutfi Kirdar Kartal Education and Research Hospital, ┼żemsi Denizer Cad E 5 Karayolu Cevizli Mevkii, 34890, Kartal Istanbul, Turkey
    Clin Transl Oncol 15:535-40. 2013
    ..Small cell lung cancer (SCLC) has a high relapse rate despite being very chemosensitive. The efficacy of second-line treatment is dismal. Our aim was to evaluate the outcome of second-line treatment...
  23. ncbi request reprint A case of Kikuchi-Fujimoto disease misdiagnosed as Hodgkin's lymphoma: the importance of second opinion
    F Dane
    Division of Medical Oncology, Department of Pathology, Marmara University School Medicine, Istanbul, Turkey
    J BUON 14:309-11. 2009
    ..Ultimately her diagnosis was corrected as KFD after second opinion of the pathology specimens. We herein provide a brief review about KFD and the importance of second opinion of the pathology specimens...
  24. ncbi request reprint Outcome of rectal and sigmoid carcinoma patients receiving adjuvant chemoradiotherapy in Marmara University Hospital
    P F Yumuk
    Division of Medical Oncology, Marmara University Medical School Hospital, Tophanelioglu C 13 15, Altunizade, Uskudar, 81190 Istanbul, Turkey
    J Chemother 15:603-6. 2003
    ..Protracted short-term infusion of 5-fluorouracil during pelvic irradiation is a safe treatment modality. Further studies are needed to improve the local control of high-risk rectal and sigmoid carcinomas...
  25. ncbi request reprint Profile of the colorectal (CRC) cancer (Ca) patients (PTS) in Turkey: A cross-sectional disease registry study-A Turkish Oncology Group trial
    N Aykan
    University of Istanbul, Istanbul, Turkey Medical Oncology Department, Istanbul Bilim University School of Medicine, Istanbul, Turkey Istanbul University Institute of Oncology, Istanbul, Turkey Hacettepe University, Ankara, Turkey Medical Oncology Department, Marmara University Hospital, Istanbul, Turkey Department of Medical Oncology, Akdeniz University, Antalya, Turkey Department of Medical Oncology, Erciyes University Medical Faculty, Kayseri, Turkey Pamukkale University Denizli, Istanbul, Turkey Gaziantep University Hospital, Gaziantep, Turkey Ankara University, Ankara, Turkey
    J Clin Oncol 29:394. 2011
    ..394 Background: CRC Ca is one of the most common Ca worldwide. This study was designed to determine the profile of recently diagnosed CRC Ca pts in Turkey...
  26. ncbi request reprint Weight gain after adjuvant treatment in breast cancer patients in Istanbul, Turkey
    N S Turhal
    Marmara University Hospital, Istanbul, Turkey Kartal Research and Education Hospital, Istanbul, Turkey
    J Clin Oncol 27:e11620. 2009
    ..e11620 Background: Weight gain is a common and unwanted result of chemotherapy. We wanted to find out how much weight Turkish beast cancer patients gains after chemotherapy and whether it lasts afterwards...
  27. doi request reprint Concurrent chemoradiotherapy with low dose weekly gemcitabine in medically inoperable muscle-invasive bladder cancer patients
    B M Atasoy
    Department of Radiation Oncology, Marmara University School of Medicine, Istanbul, Turkey
    Clin Transl Oncol 16:91-5. 2014
    ..We aimed to determine the efficacy and the toxicity of low dose weekly gemcitabine with radiation therapy in medically unfit muscle-invasive bladder cancer patients...
  28. ncbi request reprint An evaluation of lifestyle changes in cancer patients after diagnosis
    N S Turhal
    Department of Internal Medicine, Division of Oncology, Marmara University Medical Faculty, Istanbul, Turkey
    J BUON 18:760-6. 2013
    ..For this reason, we examined the lives of patients subsequent to their diagnosis and sought to determine any changes in their lifestyles...
  29. ncbi request reprint HPV DNA frequency and subset analysis in human breast cancer patients' normal and tumoral tissue samples
    M Gumus
    Department of Internal Medicine, Division of Medical Oncology, Dr Lutfi Kirdar Kartal Research and Training Hospital, Istanbul, Turkey
    J Exp Clin Cancer Res 25:515-21. 2006
    ..HPV DNA was significantly associated with breast tumor tissue compared to normal breast tissue. Additional studies looking at HPV and HPV subtypes are needed to clarify the etiological role of the HPV in breast cancer...
  30. ncbi request reprint Toxicity and feasibility analysis for cisplatin-based concomitant chemoradiotherapy in locally advanced nasopharyngeal carcinoma
    B M Atasoy
    Department of Radiation Oncology, Division of Medical Oncology, Marmara University Medical School, Istanbul, Turkey
    J BUON 13:43-50. 2008
    ..To assess the side effects of cisplatin-based concurrent chemoradiotherapy (CRT) for locally advanced nasopharyngeal carcinoma (NPC)...
  31. ncbi request reprint Synchronous renal cell carcinoma and multiple myeloma: report of two cases and review of the literature
    M A Ozturk
    Department of Internal Medicine, Marmara University School of Medicine, Istanbul, Turkey
    J BUON 14:511-4. 2009
    ....
  32. ncbi request reprint Cancer-related false knowledge in relatives of cancer patients and the general public
    N S Turhal
    Marmara University, School of Medicine, Department of Medical Oncology, Istanbul, Turkey
    J BUON 15:310-3. 2010
    ....
  33. ncbi request reprint Anxiety and depression in Turkish breast cancer patients
    N S Turhal
    Marmara University, School of Medicine, Department of Medical Oncology, Istanbul, Turkey
    J BUON 15:720-5. 2010
    ..we investigated the anxiety and depression rates in breast cancer patients (BCPs) and compared their rates with a group of unemployed women attending courses at a local government agency to increase their chances for employment...
  34. ncbi request reprint The association between sociodemographic parameters and the use of complementary interventions in patients with cancer in Turkey: A Turkish Oncology Group study
    N S Turhal
    Medical Oncology Department, Marmara University Hospital, Istanbul, Turkey Hacettepe University Hospital, Ankara, Turkey Hacettepe University, Ankara, Turkey Ege University, Izmir, Turkey Gazi University Medical School, Ankara, Turkey Ankara University School of Medicine, Ankara, Turkey Department of Medical Oncology, Baskent University Faculty of Medicine, Adana, Turkey Karadeniz Technical University, Trabzon, Turkey Gaziantep University, Gaziantep, Turkey
    J Clin Oncol 29:e19598. 2011
    ..e19598 Background: The extent of the use of complementary interventions has not yet been assessed in a multicentre study in the entire country...
  35. ncbi request reprint D-dimer--can it be a marker for malignant gastric lesions?
    Mehmet Aliustaoglu
    Acta Oncol 43:770-1. 2004